腾达建设(600512) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥699,462,337.55, a decrease of 7.46% compared to ¥755,826,600.84 in the same period last year[4]. - Net profit attributable to shareholders decreased by 49.23% to ¥58,718,900.09 from ¥115,658,977.23 year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 56.09% to ¥57,603,098.41 from ¥131,190,922.46 in the previous year[4]. - Basic and diluted earnings per share were both ¥0.04, down 42.86% from ¥0.07 in the previous year[5]. - The weighted average return on equity decreased to 0.94% from 1.85%, a drop of 0.91 percentage points[5]. - The company reported a total comprehensive income of CNY 23,194,162.13 for Q1 2025, down from CNY 128,772,209.67 in Q1 2024[21]. - The net profit for Q1 2025 was CNY 101,672,971.50, a decrease of 58.6% compared to CNY 244,977,271.91 in Q1 2024[32]. - Operating profit for Q1 2025 was CNY 106,949,115.46, down 57.8% from CNY 252,988,801.83 in the same period last year[32]. - The total profit for Q1 2025 was CNY 106,696,250.24, down 57.5% from CNY 250,819,442.34 in Q1 2024[32]. Cash Flow and Assets - The net cash flow from operating activities was negative at -¥477,041,799.48, a significant decline from ¥6,093,793.47 in the same period last year, representing a decrease of 7,928.32%[4]. - Cash received from sales of goods and services in Q1 2025 was CNY 878,517,971.69, a significant decrease of 40.54% from CNY 1,479,758,137.27 in Q1 2024[24]. - The company's cash flow from operating activities showed a net increase of CNY 92,074,030.68 in Q1 2025, compared to CNY 36,574,399.92 in Q1 2024[24]. - The company's cash and cash equivalents at the end of the period were approximately ¥1.99 billion, down from ¥2.60 billion at the end of the previous period[26]. - The cash and cash equivalents at the end of Q1 2025 were CNY 1,907,953,646.77, down from CNY 2,453,520,087.25 at the end of Q1 2024[35]. - The total cash outflow from investing activities was ¥10.03 million, leading to a net cash flow from investing activities of -¥7.16 million, a significant decline from ¥530.32 million in the prior period[25]. - The company reported a net cash outflow from investing activities of CNY 236,126,660.22 in Q1 2025, compared to a net inflow of CNY 3,280,217.90 in Q1 2024[34]. Assets and Liabilities - Total assets at the end of the reporting period were ¥10,448,034,221.28, down 4.36% from ¥10,924,176,929.81 at the end of the previous year[5]. - Total liabilities decreased to CNY 4,186,364,066.99 in Q1 2025 from CNY 4,665,419,165.45 in Q1 2024, a reduction of 10.26%[17]. - The total liabilities decreased to approximately ¥4.02 billion from ¥4.65 billion, reflecting a reduction in both current and non-current liabilities[29]. - Current assets decreased from CNY 7,709,051,641.42 to CNY 7,262,253,399.66, a reduction of about 5.78%[15]. - Cash and cash equivalents decreased from CNY 2,598,828,223.09 to CNY 2,123,078,295.21, a decline of approximately 18.36%[14]. - Accounts receivable decreased from CNY 366,682,645.21 to CNY 302,205,552.09, a decrease of about 17.59%[15]. - Non-current assets decreased slightly from CNY 3,215,125,288.39 to CNY 3,185,780,821.62, a decrease of about 0.91%[15]. - Total assets decreased from CNY 10,924,176,929.81 as of December 31, 2024, to CNY 10,448,034,221.28 as of March 31, 2025, representing a decline of approximately 4.35%[14]. Shareholder Information - The company reported a total of 62,819 common shareholders at the end of the reporting period[11]. - The top 10 shareholders hold a combined 19.80% of the total shares, with the largest shareholder owning 8.26%[11]. - The company has no significant changes in the shareholding structure compared to the previous period[12]. - There are no significant related party transactions or actions among the major shareholders[12]. Costs and Expenses - Total operating costs for Q1 2025 were CNY 700,331,055.52, down from CNY 734,154,294.85 in Q1 2024, reflecting a reduction of 4.61%[19]. - Research and development expenses for Q1 2025 were CNY 20,523,567.09, down from CNY 25,225,661.48 in Q1 2024, indicating a reduction of 18.66%[20]. - Research and development expenses for the first quarter were approximately ¥20.52 million, down from ¥25.23 million in the same period last year, indicating a focus on cost management[31]. - The company incurred credit impairment losses of CNY 34,375,892.07 in Q1 2025, compared to CNY 40,285,943.80 in Q1 2024[32].